Kvi. Rolston et al., IN-VITRO ACTIVITIES OF ANTIMICROBIAL AGENTS AGAINST CLINICAL ISOLATESOF FLAVIMONAS-ORYZIHABITANS OBTAINED FROM PATIENTS WITH CANCER, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2504-2505
We evaluated the in vitro activities of 21 different antimicrobial age
nts against nine clinical isolates of Flavimonas oryzihabitans obtaine
d from patients with cancer. The organisms were susceptible to most ag
ents commonly used for the empiric therapy (aminoglycosides, ureidopen
icillins, extended-spectrum cephalosporins, monobactams, and carbapene
ms) and prevention of infections (quinolones and trimethoprim-sulfamet
hoxazole) in this patient population.